116 related articles for article (PubMed ID: 6394594)
1. Similarity and dissimilarity between phorbol ester tumor promoters and 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3.
Kuroki T; Suda T
Princess Takamatsu Symp; 1983; 14():89-99. PubMed ID: 6394594
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of tumor promotion by 1 alpha, 25-dihydroxyvitamin D3, an active form of vitamin D3].
Kuroki T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):766-72. PubMed ID: 3754414
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by 1 alpha, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B.
Chida K; Hashiba H; Suda T; Kuroki T
Cancer Res; 1984 Apr; 44(4):1387-91. PubMed ID: 6423272
[TBL] [Abstract][Full Text] [Related]
5. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor promotion in mouse skin by 1 alpha,25-dihydroxyvitamin D3.
Chida K; Hashiba H; Fukushima M; Suda T; Kuroki T
Cancer Res; 1985 Nov; 45(11 Pt 1):5426-30. PubMed ID: 3840412
[TBL] [Abstract][Full Text] [Related]
7. Synergism and antagonism in the effects of 1 alpha,25-dihydroxyvitamin D3, retinoic acid, dexamethasone, and a tumor-promoting phorbol ester on the functional capability of P388D1 cells: phagocytosis and transglutaminase activity.
Goldman R
Cancer Res; 1985 Jul; 45(7):3118-24. PubMed ID: 2860969
[TBL] [Abstract][Full Text] [Related]
8. Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH; Hennings H; Lichti U
J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1993 May; 53(10 Suppl):2217-20. PubMed ID: 8485706
[TBL] [Abstract][Full Text] [Related]
10. Regulation of epidermal transglutaminase activity and terminal differentiation by retinoids and phorbol esters.
Yuspa SH; Ben T; Lichti U
Cancer Res; 1983 Dec; 43(12 Pt 1):5707-12. PubMed ID: 6139162
[TBL] [Abstract][Full Text] [Related]
11. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
Hashiba H; Fukushima M; Chida K; Kuroki T
Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
13. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
14. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
[TBL] [Abstract][Full Text] [Related]
17. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1,25-dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells.
Suematsu Y; Nishizawa Y; Shioi A; Hino M; Tahara H; Inaba M; Morii H; Otani S
J Cell Physiol; 1995 Dec; 165(3):547-55. PubMed ID: 7593234
[TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]